Pathstone Holdings, LLC CLGN COLLPLANT BIOTECHNOLOGIES LT

Ownership history in Pathstone Holdings, LLC  ·  7 quarters on record

AI Ownership Summary

Pathstone Holdings, LLC reported COLLPLANT BIOTECHNOLOGIES LT (CLGN) in 7 quarterly 13F filings from 2024 Q3 through 2026 Q1. The latest visible filing shows CLGN at 0.00% of the fund.

This page tracks quarterly shares, estimated market value, portfolio weight, filing dates, and disclosure-aligned stock prices directly from SEC EDGAR 13F filings.

What this CLGN ownership page tells you

This page is designed to answer the real investor question behind a 13F filing: how meaningful was Pathstone Holdings, LLC's position in COLLPLANT BIOTECHNOLOGIES LT, and how did that conviction change over time? You can read the holding window, peak weight, latest reported size, disclosure timing, and quarter-by-quarter changes without piecing the story together from raw SEC rows.

Freshest filing
Latest Reported Filing
2026 Q1

CLGN was reported at 0.00% of portfolio in the most recent visible filing.

High-water mark
Peak Conviction
0.0% in 2024 Q3

Peak weight helps separate a token disclosure from a real conviction holding the fund genuinely cared about.

Time in book
Holding Window
2024 Q3 to 2026 Q1

Longer holding windows often tell a very different story from short-lived tactical trades or one-quarter experiments.

Decision context
Why It Matters
Position size beats headlines

Knowing that a fund owned a stock is useful. Knowing whether it was a 0.20% placeholder or a true high-conviction position is where the signal actually starts.

How Pathstone Holdings, LLC held CLGN — position size vs. price
% of Fund (quarterly)    CLGN price (quarter-end, indexed to 100)    SPY (indexed to 100)    QQQ (indexed to 100)
📋 Quarterly Holdings History 7 quarters  
Quarter Action Sold % After 3M Timing Shares Change Chg % % of Fund Mkt Value Filed Price (Filed)
2026 Q1 ADDED 57,000 +40,000 +235.3% 0.00% $31K 2026-05-11 $0.39
2025 Q4 UNCHANGED 17,000 0% 0.00% $24K 2026-02-13 $0.72
2025 Q3 REDUCED 50.0% -46.5% 17,000 -17,000 -50.0% 0.00% $46K 2025-11-13 $1.98
2025 Q2 ADDED 34,000 +17,000 +100.0% 0.00% $23K 2025-08-12 $3.15
2025 Q1 UNCHANGED 17,000 0% 0.00% $44K 2025-05-15 $1.65
2024 Q4 UNCHANGED 17,000 0% 0.00% $61K 2025-02-14 $3.60
2024 Q3 INITIATED 17,000 0.00% $84K 2024-11-07 $3.79

FAQ About Pathstone Holdings, LLC and CLGN

These are the practical questions this page is built to answer before you even open the full history table.

How long has Pathstone Holdings, LLC reported owning CLGN?

Pathstone Holdings, LLC reported CLGN across 7 quarterly 13F filings, from 2024 Q3 through 2026 Q1.

What was the largest reported CLGN position in Pathstone Holdings, LLC's portfolio?

The largest reported portfolio weight for CLGN was 0.00% in 2024 Q3.

What is the latest reported CLGN position on this page?

The most recent filing on this page is 2026 Q1, when Pathstone Holdings, LLC reported 57,000 shares, equal to 0.00% of portfolio, with an estimated market value of $31K.

What does the chart on this CLGN ownership page compare?

The chart compares Pathstone Holdings, LLC's quarterly CLGN portfolio weight with the stock's indexed share price, so you can see whether the fund was building, trimming, or holding the position as price moved.

How well did Pathstone Holdings, LLC time their CLGN position?

Based on 13F filing dates vs. subsequent CLGN price moves, Pathstone Holdings, LLC correctly timed 1 out of 3 reported position changes (33%). The annualised alpha on CLGN relative to SPY over the holding period was -81.1%.

← Back to Pathstone Holdings, LLC Holdings